These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37477904)
1. Carboxymethylated Alginate-Resiquimod Micelles Reverse the Immunosuppressive Tumor Microenvironment and Synergistically Enhance the Chemotherapy and Immunotherapy for Gastric Cancer. Chen J; Liu X; Zhao S; Chen H; Lu T; Wang J; Han J; Wu W; Shen X; Li C ACS Appl Mater Interfaces; 2023 Aug; 15(30):35999-36012. PubMed ID: 37477904 [TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy. Dang BN; Duwa R; Lee S; Kwon TK; Chang JH; Jeong JH; Yook S J Control Release; 2024 Aug; 372():587-608. PubMed ID: 38942083 [TBL] [Abstract][Full Text] [Related]
4. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors. Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT Front Immunol; 2023; 14():1334800. PubMed ID: 38259462 [TBL] [Abstract][Full Text] [Related]
5. The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer. Zhou J; Xu Y; Wang G; Mei T; Yang H; Liu Y Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35552764 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246 [TBL] [Abstract][Full Text] [Related]
7. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy. Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808 [TBL] [Abstract][Full Text] [Related]
8. Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses. Li S; Chen Y; Ma R; Du Y; Han B Front Pharmacol; 2023; 14():1142374. PubMed ID: 37063284 [No Abstract] [Full Text] [Related]
9. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer. Huang S; Wen T; Wang J; Wei H; Xiao Z; Li B; Shuai X Acta Biomater; 2024 Mar; 176():344-355. PubMed ID: 38244662 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronate-Based Self-Stabilized Nanoparticles for Immunosuppression Reversion and Immunochemotherapy in Osteosarcoma Treatment. Zhang Y; Yuan T; Li Z; Luo C; Wu Y; Zhang J; Zhang X; Fan W ACS Biomater Sci Eng; 2021 Apr; 7(4):1515-1525. PubMed ID: 33793187 [TBL] [Abstract][Full Text] [Related]
11. Gold Nanorods and Polymer Micelles Mediated Dual TLR Stimulators Delivery System CPG@Au NRs/M-R848 Regulate Macrophages Reprogramming and DC Maturation for Enhanced Photothermal Immunotherapy of Melanoma. Jia Y; Shi K; Dai L; He X; Deng H; Han R; Yang F; Chu B; Liao J; Wei X; Qian Z Small Methods; 2023 May; 7(5):e2201087. PubMed ID: 36572641 [TBL] [Abstract][Full Text] [Related]
12. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053 [TBL] [Abstract][Full Text] [Related]
13. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages. Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947 [TBL] [Abstract][Full Text] [Related]
14. Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study. Thauvin C; Widmer J; Mottas I; Hocevar S; Allémann E; Bourquin C; Delie F Eur J Pharm Biopharm; 2019 Jun; 139():253-261. PubMed ID: 30981947 [TBL] [Abstract][Full Text] [Related]
15. Heat-Confined Tumor-Docking Reversible Thermogel Potentiates Systemic Antitumor Immune Response During Near-Infrared Photothermal Ablation in Triple-Negative Breast Cancer. Revuri V; Rajendrakumar SK; Park MS; Mohapatra A; Uthaman S; Mondal J; Bae WK; Park IK; Lee YK Adv Healthc Mater; 2021 Nov; 10(21):e2100907. PubMed ID: 34541833 [TBL] [Abstract][Full Text] [Related]
16. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes. Wang D; Wan Z; Yang Q; Chen J; Liu Y; Lu F; Tang J Drug Deliv; 2022 Dec; 29(1):702-713. PubMed ID: 35236203 [TBL] [Abstract][Full Text] [Related]
17. Enhancing antibody-dependent cellular phagocytosis by Re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes. Li H; Somiya M; Kuroda S Biomaterials; 2021 Jan; 268():120601. PubMed ID: 33338932 [TBL] [Abstract][Full Text] [Related]
18. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages. Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523 [TBL] [Abstract][Full Text] [Related]
19. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789 [TBL] [Abstract][Full Text] [Related]
20. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response. Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]